Frontier Space Technologies secures £191k for orbital biotech labs

Developing autonomous microgravity platforms for the life sciences sector is the primary focus of Frontier Space Technologies Ltd. The company manufactures hardware such as an in-space bioreactor and a lab-in-a-box to support biological research and manufacturing in orbit. These systems enable researchers to conduct protein crystallisation, antibody development, and cell culture experiments in space.

The startup, which is based in Nottingham, targets biotech firms and life-science researchers that require specialised on-orbit R&D capabilities for preclinical drug testing. Since its incorporation in 2021, the business has focused on providing these orbital manufacturing solutions.

A recent funding round saw the company secure an estimated £191k. This investment results in an estimated post-money valuation of £990.1k for the firm. While the formal filing for the round occurred in May, the allotment of shares took place in April.

According to its latest accounts for the year ended 31 March 2025, the business had a headcount of 9 employees.